Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease

Recruiting N/A Interventional Study
Peripheral Artery Disease Diabetes Mellitus Chronic Limb-Threatening Ischemia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
192 (estimated)
Sponsor
Nationwide Children's Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The aim of this clinical study is to 1) establish a healthy database for nuclear perfusion imaging of the lower extremities and 2) assess the prognostic value of radiotracer-based perfusion imaging for predicting clinical outcomes in patients with peripheral artery disease (PAD) who are undergoing lower extremity revascularization procedures. We hypothesize that radiotracer imaging of the lower ex…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria for Patients with Peripheral Artery Disease: 1. At least 18 years of age 2. Evidence of significant obstructive disease for one or multiple lower extremity arteries, as identified by prior ABI, TBI, CT angiography, ultrasound, or MR imaging. Exclusion Criteria for Patients with …
Contacts

Mitchel R Stacy, Ph.D.

614-355-5836

Mitchel.Stacy@nationwidechildrens.org

CONTACT